banner
p38-MAPK inhibitor LY2228820, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ901

p38-MAPK inhibitor LY2228820, Purity ≥98%

Synonym: 862507-23-1; LY2228820; Ralimetinib mesylate; Ralimetinib dimesylate; LY2228820 diMesylate; Ralimetinib mesilate; p38-MAPK inhibitor

  • MDL: MFCD22572532
  • CAS Number: 862507-23-1
  • Compound CID: 11570805
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
LY2228820, soluble in warmed DMSO, warmed water and ethanol, targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates. It targets p38α.
Molecular Weight
612.7
Molecular Formula
C24H29FN6.2CH4O3S
Targets
p38α: 7 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 4 mg/mL (6.52 mM); Warmed water: 91 mg/mL (148.51 mM); Ethanol: 3 mg/mL (4.89 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
LY2228820 serves as a research tool in evaluating the inhibition of p38 MAPK alpha and beta isoforms related to inflammatory diseases and cancer.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0